CEST-MRI is an emerging molecular imaging method for non-invasive assessment of cardiomyocyte metabolites. In cardiac CEST-MRI, spatial B1 inhomogeneity across the myocardium significantly reduces the accuracy of measured CEST contrasts. Deviation from the prescribed B1 leads to altered creatine CEST contrast due to both reduced labeling efficiency and heightened magnetization transfer and direct water direct saturation across the heart. The final impact is measurement of falsely and substantially reduced creatine CEST contrast in the healthy heart.
This abstract and the presentation materials are available to members only; a login is required.